BPG is committed to discovery and dissemination of knowledge
Articles in Press
6/10/2025 6:53:18 AM | Browse: 27 | Download: 0
Category |
Endocrinology & Metabolism |
Manuscript Type |
Letter to the Editor |
Article Title |
Limitations of glycated hemoglobin and emerging biomarkers for diabetes care after bariatric surgery
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Uchenna Esther Okpete and Haewon Byeon |
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education |
NRF- RS 2023-00237287 |
|
Corresponding Author |
Haewon Byeon, Associate Professor, Director, PhD, Worker's Care & Digital Health Lab, Department of Future Technology, Korea University of Technology and Education, 1600, Chungjeol-ro, Cheonan 31253, South Korea. bhwpuma@naver.com |
Key Words |
Bariatric surgery; Obesity management; Diabetes mellitus; Glycemic control; Biological markers; Glycated hemoglobin; Glycated Albumin; 1,5-anhydroglucitol; Diabetes remission |
Core Tip |
Alternative biomarkers to glycated hemoglobin (HbA1c), such as glycated albumin (GA) and 1,5-anhydroglucitol (1,5-AG), can provide better monitoring of glycemic control post-bariatric surgery by overcoming some of the limitations of using HbA1c in this respect. Although GA and 1,5-AG offer significant advantages for short-term and real-time glycemic monitoring, challenges such as assay standardization and lack of consensus on optimal protocols must be addressed before these biomarkers can be routinely implemented in clinical practice. Further validation is needed for their effective use in post-bariatric surgery diabetes management. |
Citation |
Okpete UE, Byeon H. Limitations of glycated hemoglobin and emerging biomarkers for diabetes care after bariatric surgery. World J Diabetes 2025; In press |
 |
Received |
|
2025-03-31 13:55 |
 |
Peer-Review Started |
|
2025-04-01 08:57 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2025-04-15 04:06 |
 |
Revised |
|
2025-04-28 21:26 |
 |
Second Decision |
|
2025-06-10 02:40 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2025-06-10 06:53 |
 |
Articles in Press |
|
2025-06-10 06:53 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
ISSN |
1948-9358 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345